Search results
Lomi Kriel
The Raw Story· 5 days agoWhile celebrating last month’s U.S. Supreme Court decision overturning the constitutional right to an abortion, Gov. Greg Abbott pointed to the millions of dollars in spending that state lawmakers ...
Letters to the Editor: Apparently the CAIR calendar is missing a date
Pioneer Press· 1 day agoThe Council on American-Islamic Relations (National), has called on the Biden administration to...
These New Pregnancy Rules Could Upend the Workplace
newser· 4 days agoNew law: This legislation treats pregnancy and related conditions as themselves deserving of "reasonable accommodations" and places the burden on...
Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal
Zacks via Yahoo Finance· 6 days agoData from a mid-stage study show that Sage's (SAGE) experimental oral drug failed to show a...
Bennett Braun, psychiatrist who inflamed a ‘satanic panic,’ dies at 83
Washington Post· 6 days agoBennett Braun, a psychiatrist who inflamed the 1980s “satanic panic” with his controversial ...
Abortion restrictions, attacks on DEI threaten Black maternal health, roundtable participants say
NC Newsline via Yahoo News· 5 days agoBlack women working to improve Black maternal health assessed recent successes and new roadblocks to...
New pregnant worker rights: What to expect when expecting
WJZY via Yahoo News· 2 days agoPregnant employees have the right to a wide range of accommodations under new federal regulations...
What to Know About New Rights for Pregnant Workers
Insurance Journal· 1 day agoEmployment Opportunity Commission, the agency in charge of enforcing the law, adopted an expansive view of conditions related to pregnancy and childbirth...
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Detroit News· 1 day agoEmployment Opportunity Commission, the agency in charge of enforcing the law, adopted an expansive...
Sage Therapeutics (NASDAQ:SAGE) Price Target Cut to $17.00 by Analysts at Oppenheimer
ETF DAILY NEWS· 6 days agoSage Therapeutics (NASDAQ:SAGE – Free Report) had its price objective cut by Oppenheimer from $25.00 to $17.00 in a research note released on Thursday morning, Benzinga reports. Other equities ...